Senior Senators Seek Details On Government Audits Of 340B Entities
This article was originally published in The Pink Sheet Daily
Executive Summary
Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.